Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
M&M.NS Stock Summary
Top 10 Correlated ETFs
M&M.NS
In the News

Cincinnati Earnings Roundup: Part 1
The latest earnings season has come and gone.

3 Cheap Blue-Chip Stocks Under $15 to Buy Now
In the last 18 months, many high-quality stocks took huge hits as investors waited for the recession that hasn't come and that, in my opinion, will not arrive any time soon. Given the huge pullbacks that these names underwent, there are plenty of affordable blue-chip stocks under $15 to buy.

New Strong Sell Stocks for June 6th
BANC, DCP and M have been added to the Zacks Rank #5 (Strong Sell) List on June 6, 2023.

Is Macy's an Excellent Stock to Buy Now?
Macy's latest quarter was worse than what management was expecting.

Nike Inks Wholesale Deal With Macy's After Yearlong Breakup
Nike products will return to Macy's later this year after the athletic shoemaker and department store giant reached a fresh wholesale agreement.

A Conservative Strategy For Playing Macy's Already Low Valuation
Macy's stock is undervalued with a potential 50% upside after a 31.5% decline over the last three months. The company has improved cost efficiency, expanded its brands, and focused on personalized offers through technology. M's current valuation and dividend yield provide a strong margin of safety for investors, who can also consider selling cash-secured puts for a more conservative strategy.

Macy's First Quarter Sales And Earnings Has Boosters
Macy's reported net sales in their first quarter that were $5.0 billion, a 7% decline over last years $5.3 Billion.

Macy's (M) Q1 Earnings Beat Estimates, Comp Sales Decline
Macy's (M) reports an earnings beat in first-quarter fiscal 2023. However, sales were soft due to a comparable sales decline of 7.9% on an owned basis.

What Macy's & Dollar General earnings are telling us about the consumer and inflation
High inflation and economic uncertainty has led consumers to pull back on their spending. Forrester Research Retail Analyst Sucharita Kodali explains what the impact will be on retail stocks.

Macy's Navigates Weak Consumer Demand, Continues Deep Discounts
Earlier, PYMNTS reported that the summer of markdowns is here as Macy's (along with Dollar General) struggled with declining consumer demand. The retailer has now revised its annual sales and profit forecasts downward, citing a deceleration in demand caused by inflation as the primary factor.
M&M.NS Financial details
M&M.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 836.4 | 947.87 | 848.97 | 660.42 | 803.43 | |
Net income per share | 69.2 | 48.91 | -2.91 | 33.37 | 59.2 | |
Operating cash flow per share | 6.28 | -40 | -13.14 | 161.43 | 83.24 | |
Free cash flow per share | -48.14 | -107.54 | -75.58 | 107.44 | 28.87 | |
Cash per share | 112.25 | 138.88 | 133.56 | 211.22 | 204.26 | |
Book value per share | 338.86 | 367.9 | 361.89 | 374.82 | 424.17 | |
Tangible book value per share | 342.87 | 361.45 | 344.82 | 392.02 | 441.45 | |
Share holders equity per share | 338.86 | 367.9 | 361.89 | 374.82 | 424.17 | |
Interest debt per share | 550.81 | 697.06 | 801.34 | 780.76 | 742.79 | |
Market cap | 811.82B | 718.27B | 314.71B | 882.23B | 896.03B | |
Enterprise value | 1326.13B | 1365.36B | 1092.93B | 1654.73B | 1637.21B | |
P/E ratio | 10.81 | 13.51 | -98.04 | 23.83 | 13.62 | |
Price to sales ratio | 0.89 | 0.7 | 0.34 | 1.2 | 1 | |
POCF ratio | 119.06 | -16.52 | -21.69 | 4.93 | 9.69 | |
PFCF ratio | -15.54 | -6.15 | -3.77 | 7.4 | 27.93 | |
P/B Ratio | 2.21 | 1.8 | 0.79 | 2.12 | 1.9 | |
PTB ratio | 2.21 | 1.8 | 0.79 | 2.12 | 1.9 | |
EV to sales | 1.46 | 1.33 | 1.17 | 2.26 | 1.83 | |
Enterprise value over EBITDA | 7.78 | 8 | 8.1 | 10.14 | 9.62 | |
EV to operating cash flow | 194.49 | -31.41 | -75.33 | 9.24 | 17.7 | |
EV to free cash flow | -25.39 | -11.68 | -13.09 | 13.88 | 51.04 | |
Earnings yield | 0.09 | 0.07 | -0.01 | 0.04 | 0.07 | |
Free cash flow yield | -0.06 | -0.16 | -0.27 | 0.14 | 0.04 | |
Debt to equity | 2.51 | 2.88 | 2.99 | 2.79 | 2.49 | |
Debt to assets | 0.67 | 0.7 | 0.71 | 0.7 | 0.67 | |
Net debt to EBITDA | 3.02 | 3.79 | 5.77 | 4.73 | 4.36 | |
Current ratio | 1.2 | 1.18 | 1.19 | 1.4 | 1.34 | |
Interest coverage | 2.56 | 2.29 | 1.43 | 1.99 | 2.75 | |
Income quality | 0.09 | -0.82 | -0.56 | 5.89 | 1.3 | |
Dividend Yield | 0.01 | 0.01 | 0.04 | 0 | 0.01 | |
Payout ratio | 0.11 | 0.18 | -3.54 | 0.07 | 0.15 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.04 | 0.04 | |
Capex to operating cash flow | -8.66 | 1.69 | 4.75 | -0.33 | -0.65 | |
Capex to revenue | -0.07 | -0.07 | -0.07 | -0.08 | -0.07 | |
Capex to depreciation | -1.8 | -1.84 | -1.39 | -1.36 | -1.72 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 726.39 | 636.28 | 153.84 | 530.49 | 751.69 | |
ROIC | 0.07 | 0.06 | -0.01 | 0.06 | 0.07 | |
Return on tangible assets | 0.06 | 0.03 | 0 | 0.02 | 0.04 | |
Graham Net | -694.18 | -863.58 | -896.72 | -789.37 | -799.29 | |
Working capital | 99.26B | 106.63B | 100.36B | 206.92B | 188.6B | |
Tangible asset value | 372.09B | 392.83B | 380.84B | 434.89B | 490.42B | |
Net current asset value | -331.09B | -456.42B | -553B | -436.72B | -421.4B | |
Invested capital | 1.52 | 1.77 | 2.07 | 1.94 | 1.65 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 169.16B | 196.4B | 179.89B | 152.46B | 172.71B | |
Average inventory | 91.11B | 107.68B | 116.56B | 103.64B | 106.06B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 127.36 | 129.21 | 104.08 | 147.1 | 133.68 | |
Days of inventory on hand | 65.02 | 75.09 | 77.18 | 91.22 | 81.43 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.87 | 2.82 | 3.51 | 2.48 | 2.73 | |
Inventory turnover | 5.61 | 4.86 | 4.73 | 4 | 4.48 | |
ROE | 0.2 | 0.13 | -0.01 | 0.09 | 0.14 | |
Capex per share | -54.42 | -67.54 | -62.44 | -53.99 | -54.37 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 212.39 | 225.23 | 255.45 | 268.57 | 275.14 | |
Net income per share | 22.37 | 20.14 | 19.74 | 24.93 | 24.05 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 204.27 | 0 | 219.96 | 0 | |
Book value per share | 0 | 424.18 | 0 | 454.16 | 0 | |
Tangible book value per share | 0 | 441.46 | 0 | 461.09 | 0 | |
Share holders equity per share | 0 | 424.18 | 0 | 454.16 | 0 | |
Interest debt per share | 0 | 708.64 | 0 | 761.14 | 0 | |
Market cap | 930.01B | 896.01B | 1215.83B | 1410.5B | 1390.25B | |
Enterprise value | 0 | 1637.19B | 0 | 2204.09B | 0 | |
P/E ratio | 9.36 | 10.01 | 13.84 | 12.72 | 12.99 | |
Price to sales ratio | 3.94 | 3.58 | 4.28 | 4.72 | 4.54 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 1.9 | 0 | 2.79 | 0 | |
PTB ratio | 0 | 1.9 | 0 | 2.79 | 0 | |
EV to sales | 0 | 6.54 | 0 | 7.38 | 0 | |
Enterprise value over EBITDA | 0 | 35.13 | 0 | 38.6 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 2.49 | 0 | 2.6 | 0 | |
Debt to assets | 0 | 0.67 | 0 | 0.68 | 0 | |
Net debt to EBITDA | 0 | 15.9 | 0 | 13.9 | 0 | |
Current ratio | 0 | 1.34 | 0 | 1.32 | 0 | |
Interest coverage | 3.24 | 3.33 | 3.36 | 3.34 | 3.03 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.04 | 0 | 0.05 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 438.42 | 0 | 504.73 | 0 | |
ROIC | 0 | 0.02 | 0 | 0.02 | 0 | |
Return on tangible assets | 0 | 0.01 | 0 | 0.02 | 0 | |
Graham Net | 0 | -799.31 | 0 | -896.1 | 0 | |
Working capital | 0 | 188.6B | 0 | 221.44B | 0 | |
Tangible asset value | 0 | 490.42B | 0 | 512.83B | 0 | |
Net current asset value | 0 | -421.4B | 0 | -394.04B | 0 | |
Invested capital | 0 | 1.65 | 0 | 1.65 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 107.37 | 0 | 109.49 | 0 | |
Days of inventory on hand | 0 | 65.4 | 0 | 72.69 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.84 | 0 | 0.82 | 0 | |
Inventory turnover | 0 | 1.38 | 0 | 1.24 | 0 | |
ROE | 0 | 0.05 | 0 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
M&M.NS Frequently Asked Questions
What is Mahindra & Mahindra Limited stock symbol ?
Mahindra & Mahindra Limited is a US stock , located in New york city of New york and trading under the symbol M&M.NS
Is Mahindra & Mahindra Limited buy or a sell ?
14 stock analysts have 14 predictions with a medium analyst target price of $27.43. The lowest prediction is $21 and the highest is $45
What is M&M.NS stock prediction ?
What is Mahindra & Mahindra Limited stock quote today ?
Mahindra & Mahindra Limited stock price is $1370.65 today.
Is Mahindra & Mahindra Limited stock public?
Yes, Mahindra & Mahindra Limited is a publicly traded company.